ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36685
-0.02%
Bitcoin
63,593.90
1.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) News

BIAF bioAffinity Technologies Inc

2.08
-0.21 (-9.17%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
bioAffinity Technologies Inc BIAF NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.21 -9.17% 2.08 18:57:06
Open Price Low Price High Price Close Price Previous Close
2.24 2.03 2.2511 2.09 2.29
more quote information »

Recent News

Date Time Source Heading
5/02/202407:00BWbioAffinity Technologies News Update
4/24/202407:00BWbioAffinity Technologies Advances New Product Development..
4/09/202407:00BWbioAffinity Technologies Expands Campaign to Support..
4/01/202408:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
3/08/202416:00EDGAR2Form 8-K - Current report
3/08/202412:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
3/08/202411:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
3/08/202411:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/07/202420:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/06/202409:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
3/06/202408:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
3/05/202416:26EDGAR2Form 8-K - Current report
3/05/202407:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
2/21/202407:00BWbioAffinity Technologies News Update
2/06/202407:00BWMedical Director of Lung Innovations Network and The Lung..
2/02/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:05EDGAR2Form 8-K - Current report
1/30/202407:00BWbioAffinity Technologies In The News
1/24/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202407:00BWbioAffinity Technologies Announces Award of Therapeutic..
1/08/202407:00BWbioAffinity Technologies In the News
12/08/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/05/202307:45EDGAR2Form 8-K - Current report
12/05/202307:00BWbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its..
11/30/202308:20EDGAR2Form 8-K - Current report
11/30/202307:00BWCMS Posts Final Payment Determination for bioAffinity..
11/28/202315:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/28/202307:00BWbioAffinity Technologies VP David Elzi, Ph.D., Named to..
11/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/16/202316:23EDGAR2Form S-3 - Registration statement under Securities Act of..
11/15/202316:07EDGAR2Form 8-K - Current report
11/15/202307:00BWbioAffinity Technologies Teams with American Cancer Society..
11/14/202315:01BWbioAffinity Technologies Reports Third Quarter 2023..
11/14/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202307:00BWbioAffinity Technologies Names Dallas J. Coleman as National..
11/03/202315:49EDGAR2Form 8-K/A - Current report: [Amend]
11/03/202315:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
10/18/202316:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202316:27EDGAR2Form 8-K - Current report
10/10/202307:00BWbioAffinity Technologies to Present at the 8th Annual Dawson..
10/10/202305:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
9/26/202315:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/25/202316:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/21/202308:35GLOBEDawson James Securities Announces October Date for 8th..
9/20/202316:29EDGAR2Form S-1 - General form for registration of securities under..

Your Recent History

NASDAQ
BIAF
bioAffinity Technologies
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved